🔗 Permalink

Inventor profile of:

Kirk W. Johnson

City:

Moraga, California

Country:

United States

Published Applications:

Last publication date:

2024-05-16

Top Assignees for applications by Kirk W. Johnson

The entities that hold a legal rights for patent applications filed by inventor Johnson Kirk W.:

MediciNova, Inc. 5 San Diego, CA United States
BAXTER INTERNATIONAL INC. 5 Deerfield, IL United States
Avigen, Inc. 5 Alameda, CA United States
BAXTER HEALTHCARE S.A. 4 Glattpark (Opfikon), Switzerland
XOMA (US) LLC 3 Emeryville, CA United States
The Regents of the University of Colorado 2 Denver, CO United States
MUSC FOUNDATION FOR RESEARCH DEVELOPMENT 2 Charleston, SC United States
Baxter Healthcare S.A. 1 Wallisellen, Switzerland
Baxalta GmbH 1 Opfikon, Switzerland
Adelaide Research & Innovation Pty Ltd. 1 Adelaide, Australia
BAXTER HEALTHCARE S. A. 1 Glattpark (Opfikon), Switzerland
BAXALTA INCORPORATED 1 Bannockburn, IL United States
Chiron Corporation 1 Emeryville, CA United States

Recent patent applications by Johnson Kirk W.

Kirk W. Johnson from Moraga, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-05-16

US20240158535A1

Chemistry; metallurgy

PARATHYROID HORMONE RECEPTOR 1(PTH1R) ANTIBODIES AND USES THEREOF

#2 | 2021-06-24

US20210188969A1

Chemistry; metallurgy

Antibodies that bind interleukin-2 and uses thereof

#3 | 2018-04-05

US20180094053A1

Chemistry; metallurgy

Antibodies that bind interleukin-2 and uses thereof

#4 | 2018-02-08

US20180037658A1

Chemistry; metallurgy

Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery

#5 | 2014-11-06

US20140328827A1

Chemistry; metallurgy

Methods for fucoidan purification from seaweed extracts

#6 | 2014-02-27

US20140056999A1

Human necessities

TREATMENT OF ACUTE EXACERBATION OF ASTHMA AND REDUCTION OF LIKELIHOOD OF HOSPITALIZATION OF PATIENTS SUFFERING THEREFROM

#7 | 2013-07-11

US20130178495A1

Human necessities

IBUDILAST FOR RELIEVING NEGATIVE EFFECTS OF MEDICATION OVERUSE HEADACHE

#8 | 2012-11-22

US20120295982A1

Human necessities

TREATING HUMAN MALE COPD PATIENTS WITH ORAL BEDORADRINE

#9 | 2012-10-04

US20120251632A1

Human necessities

Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom

#10 | 2012-05-24

US20120129777A1

Human necessities

Methods for treating bleeding disorders using sulfated polysaccharides

#11 | 2011-11-10

US20110275664A1

Human necessities

Method for treating drug and behavioral addictions

#12 | 2011-09-29

US20110237512A1

Human necessities

Methods for treating bleeding disorders using sulfated polysaccharides

#13 | 2011-05-19

US20110117213A1

Human necessities

TREATMENT OF ACUTE EXACERBATION OF ASTHMA AND REDUCTION OF LIKELIHOOD OF HOSPITALIZATION OF PATIENTS SUFFERING THEREFROM

#14 | 2011-02-17

US20110039873A1

Chemistry; metallurgy

SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITY

#15 | 2010-12-23

US20100324082A1

Chemistry; metallurgy

Enantiomeric compositions of 2-amino-1-(2-isopropylpyrazolo[1,5-α]pyridin-3-yl)propan-1-one and related methods

#16 | 2010-02-11

US20100035920A1

Chemistry; metallurgy

SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE

#17 | 2010-02-04

US20100028296A1

Human necessities

Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease

#18 | 2009-12-24

US20090318437A1

Chemistry; metallurgy

SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE

#19 | 2009-10-29

US20090269325A1

Human necessities

Methods for treating bleeding disorders using sulfated polysaccharides

#20 | 2009-04-16

US20090098185A1

Human necessities

Method for treating thrombotic disorders using sulfated polysaccharides

#21 | 2009-02-05

US20090035256A1

Human necessities

Mutant IL-10

#22 | 2009-01-29

US20090028816A1

Human necessities

Treatment of depression, psychosis, and anxiety

#23 | 2008-07-31

US20080181876A1

Human necessities

Methods for treating acute and subchronic pain

#24 | 2008-05-15

US20080114027A1

Human necessities

Method for treating delirium

#25 | 2008-05-08

US20080107678A1

Human necessities

Method for treating thrombotic disorders using sulfated polysaccharides

#26 | 2008-03-20

US20080070912A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-a]pyridine compounds and their methods of use

#27 | 2007-03-29

US20070072899A1

Human necessities

Method for treating drug and behavioral addictions

#28 | 2006-07-20

US20060160843A1

Human necessities

Method for treating neuropathic pain and associated syndromes

#29 | 2006-05-02

US10309535

Inhibitors of glycogen synthase kinase 3

#30 | 2005-12-22

US20050282771A1

Human necessities

Methods for treating bleeding disorders using sulfated polysaccharides

InventorID:

335980 ⎘